Related by context. All words. (Click for frequent words.) 79 Hb A1C 78 HbA 1c levels 78 HbA1c levels 78 hemoglobin A1c levels 77 HbA1C 77 HbA1C levels 76 glycated hemoglobin 76 baseline HbA1c 75 A1c levels 75 hemoglobin A1c HbA1c 75 HbA1c 75 glycated hemoglobin levels 74 glycosylated hemoglobin 73 hemoglobin A1C 73 serum potassium 73 A1C levels 73 glycated hemoglobin HbA1c 73 hemoglobin A1c 73 serum urate 73 fasting plasma glucose 73 sUA 73 glycemia 72 glycosylated hemoglobin HbA1c 72 #/#mmHg 72 serum uric acid 72 HOMA IR 72 fasting insulin 72 fasting glucose 72 systolic BP 72 diastolic BP 72 mm Hg systolic 71 mL/min/#.# m 2 71 Hb A1c 71 fasting plasma glucose FPG 71 #.#mmol L [002] 71 serum creatinine levels 71 intact parathyroid hormone 70 mmol l 70 lumbar spine BMD 70 #mg/dL [001] 70 fasting glucose levels 70 plasma homocysteine 70 LVEF 70 albumin excretion 70 alanine aminotransferase ALT 70 nondiabetic patients 70 serum phosphorus 70 apolipoprotein B 70 Fasting glucose 69 creatinine ratio 69 serum phosphate levels 69 urine albumin 69 EDSS score 69 -#.# mg dL [002] 69 intima media thickness 69 antihypertensive medications 69 serum triglycerides 69 mmHg diastolic 69 tHcy 69 HbA 1C 69 aminotransferases 69 serum phosphate 69 serum calcium 69 fasting blood glucose 69 mm Hg diastolic 68 A1c 68 serum sodium 68 hydroxyvitamin D levels 68 MADRS score 68 tertiles 68 serum urate levels 68 binary restenosis 68 mEq L 68 NYHA functional class 68 nonfasting triglyceride levels 68 glomerular filtration rate 68 lowest tertile 68 serum IGF 68 albumin excretion rate 68 serum glucose 68 pCR 68 #.#/#.# mmHg [001] 68 mean baseline HbA1c 68 OGTT 68 MMSE scores 68 CVD mortality 67 CI -#.# 67 Cmax 67 plasma glucose levels 67 serum cortisol 67 mg dL 67 serum testosterone 67 #mmHg [001] 67 MMSE score 67 metabolic parameters 67 x ULN 67 macroalbuminuria 67 atherogenic dyslipidemia 67 lipid lowering medications 67 μg dL 67 UACR 67 neutrophil counts 67 mmHg systolic 67 cardiovascular mortality 67 #.#mmol l [002] 67 ejection fractions 67 baseline serum creatinine 67 #.#ng/ml 67 serum PSA 67 PASI scores 67 peak VO2 67 μmol L 67 serum HBV DNA 67 leukocyte count 67 #mmHg [002] 67 serum PTH 67 hsCRP levels 67 hypertensives 67 microalbuminuria 67 antihypertensive therapy 67 tertile 67 troponin T 67 albuminuria 67 mmol L. 66 g dl 66 urinary albumin 66 arterial thromboembolic events 66 serum concentrations 66 alanine aminotransferase 66 lispro 66 p = .# [002] 66 pg mL 66 hip BMD 66 virologic response 66 diastolic blood pressures 66 elevated creatinine 66 hsCRP 66 elevated ALT 66 SCr 66 proteinuria 66 HBeAg seroconversion 66 nmol L 66 plasma glucose 66 PSA nadir 66 glycosylated hemoglobin levels 66 hemoglobin concentrations 66 irbesartan 66 eGFR 66 #mg/dL [002] 66 NPH insulin 66 PaO 2 66 CrCl 66 mIU L 66 A1C 66 antihypertensive medication 66 T2DM 66 hypoglycemic events 66 serum CRP 66 LDL C 66 mmHg 66 cholesterol LDL C 66 statistical significance p 66 ng dL 66 triglyceride concentrations 66 urinary albumin excretion 66 antibody titer 66 highest tertile 66 elevated LDL cholesterol 66 nondiabetics 66 lipid parameters 65 #.#mg/dL 65 serum magnesium 65 hs CRP 65 aspartate aminotransferase AST 65 β blockers 65 density lipoprotein cholesterol 65 baseline A1C 65 oxycodone CR 65 glomerular filtration 65 isoprostane 65 pulmonary capillary wedge 65 Hemoglobin A1c 65 NNT = 65 ng mL 65 achieved statistical significance 65 platelet inhibition 65 mm Hg 65 serum ALT 65 umol L 65 HDL C 65 mmol L 65 CDAI score 65 serum vitamin D 65 triacylglycerol concentrations 65 confidence intervals CIs 65 hemoglobin concentration 65 serum homocysteine 65 transaminases 65 carotid IMT 65 pg ml 65 hypoglycemic episodes 65 plasma leptin 65 morphometric vertebral fractures 65 Crohn Disease Activity 65 elevated homocysteine 65 serum lipid levels 65 polyp recurrence 65 apnea hypopnea index 65 nonfatal MI 65 systolic blood pressures 65 fasting triglycerides 65 homocysteine concentrations 65 MetS 65 lipid profiles 65 #mg/dl 65 serum TSH 65 PCWP 65 nmol l 65 plasma cortisol 65 BMI z 65 fasting triglyceride levels 65 creatinine clearance 65 pmol L 65 thyrotropin levels 65 systolic dysfunction 65 calculated creatinine clearance 65 nonsignificant 65 urinary oxalate 65 hypertensive patients 65 adenoma recurrence 65 LDL cholesterol levels 65 serum folate 65 iPTH 64 mU L 64 cystatin C 64 plasma triglycerides 64 periprocedural 64 triglyceride concentration 64 per deciliter mg 64 insulin detemir 64 μg L 64 #ng/ml 64 serum cholesterol 64 complete cytogenetic response 64 hemoglobin Hb 64 LDL HDL 64 impaired fasting glucose 64 CHD mortality 64 postprandial glucose 64 serum triglyceride levels 64 % Confidence Interval 64 serum ferritin 64 definite stent thrombosis 64 Triglyceride levels 64 NYHA class 64 inflammatory biomarkers 64 platelet reactivity 64 transferrin saturation 64 nmol L. 64 elevated fasting glucose 64 liver histology 64 microvascular complications 64 serum creatinine 64 aspartate aminotransferase 64 advanced adenomas 64 cTnT levels 64 fasting serum 64 multivariable analysis 64 mg dl 64 diastolic pressures 64 DAS# scores 64 biochemical recurrence 64 eplerenone 64 nicardipine 64 creatinine 64 plasma folate 64 PSADT 64 BENICAR HCT 64 endometrial thickness 64 tHcy concentrations 64 PANSS scores 64 CCyR 64 detemir 64 postoperative mortality 64 arterial stiffness 64 NATRECOR R 64 asymptomatic carotid stenosis 64 protein excretion 64 subclinical hyperthyroidism 64 serum HCV RNA 64 postintervention 64 atorvastatin #mg 64 colorectal adenoma 64 tirofiban 64 blood Phe 64 nonfasting triglycerides 64 lipid levels 64 recurrent VTE 64 Serum creatinine 64 AST ALT 64 NIHSS score 64 Fasting plasma glucose 64 #.#mmHg 64 SUVmax 64 subclinical hypothyroidism 64 Primary endpoints 64 gm dl 64 CK MB 64 creatinine levels 64 mg BID dose 64 systemic embolism 64 sustained virological response 63 estimated glomerular filtration 63 dapagliflozin plus 63 nonfasting 63 systolic blood pressure 63 waist girth 63 magnesium intake 63 lactate dehydrogenase LDH 63 Baseline characteristics 63 timepoints 63 Hb levels 63 CLA supplementation 63 serum bilirubin 63 P = .# 63 advanced adenoma 63 posttreatment 63 HDRS 63 bezafibrate 63 coronary stenosis 63 dyslipidaemia 63 SGRQ 63 mmol liter 63 #.#/#.# mm Hg [001] 63 Subgroup analyzes 63 mean serum phosphorus 63 serum retinol 63 Psoriasis Area 63 ml kg 63 serum lipid 63 systolic diastolic 63 HDL cholesterol triglycerides 63 statistically significant p = 63 Lucentis monotherapy 63 macrovascular disease 63 laboratory abnormalities 63 achieved ACR# 63 clinically meaningful improvement 63 serum phosphorous 63 beta blocker therapy 63 serum leptin 63 plasma renin 63 improves glycemic 63 femoral neck BMD 63 metformin monotherapy 63 confidence interval #.#-#.# 63 nonobese 63 cardio respiratory fitness 63 subclinical atherosclerosis 63 serum parathyroid hormone 63 Score DAS# 63 sUA levels 63 nonsignificant difference 63 subscore 63 insulin glargine 63 exhaled nitric oxide 63 nondiabetic 63 ng ml 63 lipid abnormalities 63 candesartan 63 -#.# ± [002] 63 glucose insulin 63 extrapyramidal symptoms 63 #mg/day [002] 63 abdominal adiposity 63 lipid lowering agents 63 Ishak fibrosis score 63 preoperatively 63 symptomatic intracerebral hemorrhage 63 Unified Parkinson Disease 63 urate levels 63 C reactive protein 63 serum calcium levels 63 carotid stenosis 63 serum LDL cholesterol 63 glargine 63 μg kg 63 oral antidiabetic medication 63 μg dl 63 QTcF 62 thiazide diuretics 62 ATACAND 62 total cholesterol triglycerides 62 PANSS total 62 serum folate concentrations 62 atheroma volume 62 virologic failure 62 cardiorespiratory fitness 62 thyroglobulin 62 tolvaptan 62 urinary excretion 62 adiponectin concentrations 62 elevated LDH 62 serum estradiol 62 p = #.# [003] 62 HAQ DI 62 biphasic insulin aspart 62 #.#/#.# mm Hg [003] 62 mg simvastatin 62 LDL cholesterol lowering 62 KDOQI 62 IBDQ 62 normotensive 62 certolizumab 62 multivariable adjusted 62 NIHSS 62 mL/min/#.# m2 62 DAS# [002] 62 elevated uric acid 62 6MWD 62 exhaled NO 62 urinary N telopeptide 62 univariate analysis 62 preoperative PSA 62 antihypertensive drugs 62 clinically meaningful improvements 62 QTc 62 Y BOCS 62 #OHD 62 NHANES III 62 Montgomery Åsberg Depression 62 Ejection Fraction 62 poor metabolizers 62 OADs 62 paricalcitol 62 estimated GFR 62 hematologic toxicity 62 serum BDNF 62 SGPT 62 glycaemia 62 biochemical relapse 62 cerebrovascular events 62 PUFA intake 62 dietary calcium intake 62 thyrotropin 62 plasma HCV RNA 62 undetectable viral 62 μg d 62 ACR# response 62 elevated serum creatinine 62 isolated systolic hypertension 62 HER2 expression 62 PRADAXA #mg 62 primary aldosteronism 62 mg/m2 dose 62 chlorthalidone 62 statin monotherapy 62 glulisine 62 titrated glipizide 62 rimonabant #mg 62 hypokalemia 62 reinfarction 62 HDL Cholesterol 62 CR nPR 62 serum triglyceride 62 CR CRu 62 EDSS scores 62 atherogenic lipids 62 FDG uptake 62 Insulin sensitivity 62 baseline LDH 62 triglycerides TG 62 TEAEs 62 normal ULN 62 UPDRS 62 Platelet counts 62 isoflavone intake 62 pentoxifylline 62 spirometric 62 #OHD levels 62 nmol liter 62 alanine transaminase 62 systolic 62 adiponectin levels 62 mmHg p = 62 mcg mL 62 sodium excretion 62 anemia hemoglobin 62 fraction LVEF 62 cardiovascular morbidity 62 severe exacerbations 62 AUCs 62 valsartan 62 diastolic pressure 62 glucose lowering 62 % CI #.#-#.# [006] 62 serum aminotransferase levels 62 arterial oxygen saturation 61 acrylamide intake 61 NCEP ATP III 61 postop 61 % CI #.#-#.# [003] 61 mineral density 61 fluticasone salmeterol 61 confidence interval CI 61 clinically meaningful reductions 61 nonvertebral fractures 61 recurrent venous thromboembolism 61 serum IgE 61 diastolic blood pressure 61 g dL 61 dietary sodium 61 #.#mmol L [001] 61 NIH CPSI 61 BENICAR 61 -#.# mg dL [001] 61 postdose 61 postprandial insulin 61 virological failure 61 fructosamine 61 prespecified 61 carotid intima media 61 aminotransferase levels 61 lymphocyte count 61 noninferiority 61 symptomatic intracranial hemorrhage 61 prospectively defined 61 FeNO 61 N telopeptide 61 salmeterol fluticasone propionate 61 μg liter 61 #.#/#.# mm Hg [002] 61 diuretic chlorthalidone 61 sulphonylurea 61 log# copies mL 61 P ≤ 61 eosinophil count 61 elevated IOP 61 residual platelet reactivity 61 LDL triglycerides 61 MACCE 61 dose clopidogrel 61 ejection fraction 61 LDL cholesterol concentrations 61 elevated triglycerides 61 gout flares 61 X ULN 61 plasma glucose concentration 61 tolterodine ER 61 K DOQI 61 Fasting blood glucose 61 serum selenium 61 IPSS 61 serum sodium levels 61 serologically active patients 61 GERD symptom 61 hours postdose 61 corticosteroid dose 61 elevated triglyceride levels 61 ADAS cog 61 mg d 61 arterial thickening 61 plasma lipids 61 Index CDAI 61 CK # plasma concentrations 61 placebo p 61 procalcitonin 61 overt nephropathy 61 = #.#-#.# 61 d dimer 61 gadolinium enhancing lesions 61 APTIVUS r 61 ARB telmisartan 61 cardiac autonomic 61 LV ejection fraction 61 erythrocyte sedimentation rate 61 intensive statin therapy 61 endoscopic remission 61 concomitant medications 61 aldosterone antagonist 61 HRQL 61 serum testosterone levels 61 hyperglycaemia 61 oral allopurinol 61 T2 lesions 61 mTSS 61 LV dysfunction 61 methacholine challenge 61 periprocedural MI 61 elevated CRP 61 International Prostate Symptom 61 Prehypertension 61 abdominal circumference 61 mcg BID 61 #mm Hg 61 #mg/day [001] 61 Avandia Actos 61 apo B 61 ng dl 61 macrovascular 61 PREZISTA r arm 61 YMRS 61 symptomatic VTE 61 dosage regimens 61 HIV RNA 61 oral hypoglycemic agents 61 tapentadol ER 61 systolic hypertension 61 attain statistical significance 61 antigen PSA levels 61 lactate dehydrogenase 61 salivary cortisol 61 glimepiride 61 ALLHAT 61 blood Phe levels 61 postoperative complication 61 PSQI 61 hypogonadal men 61 Subgroup analysis 61 % CI #.#-#.# [004] 61 SHBG levels 61 univariate analyzes 61 virological response 61 specific antigen PSA 61 corrected QT interval 61 moderate renal impairment 61 baseline FEV 61 incontinence episodes 60 infarct size 60 SSRI SNRI 60 antidiabetic medication 60 macrovascular events 60 transaminase levels 60 ADAS Cog 60 serum thyroglobulin 60 HAM D# scores 60 triglyceride levels 60 LS BMD 60 oral antidiabetes 60 arterial stiffening 60 plasma urate 60 LEXIVA r 60 diastolic hypertension 60 dose statin therapy 60 oral glucose tolerance 60 ALT AST 60 prolactin levels 60 uncorrected visual acuity 60 IGFBP 60 left ventricular systolic 60 angiotensin converting enzyme inhibitors 60 lipid lowering drugs 60 dietary folate intake 60 triglyceride TG 60 treatment emergent AEs 60 atazanavir ritonavir 60 leukocyte counts 60 hippocampal volume 60 angiotensin II receptor blockers 60 mmol 60 LV hypertrophy 60 plasma renin activity 60 retinal thickness 60 plasma uric acid 60 gastric pH 60 RBP4 levels 60 8 OHdG 60 ALT elevations 60 fluvastatin 60 tipranavir r 60 TT genotype 60 nonvertebral fracture 60 #mg BID [003] 60 TC HDL 60 HDL LDL ratio 60 fetuin 60 fosamprenavir 60 mL kg 60 urinary calcium 60 serum lipids 60 folate intake 60 leukopenia 60 NNRTI resistance 60 nonresponders 60 LDL lowering 60 uM 60 elevated blood glucose 60 noncardiovascular mortality 60 highest quintile 60 sotalol 60 urinary sodium excretion 60 urinary cortisol 60 colorectal neoplasia 60 clomipramine 60 Lp PLA 2 60 conventional antipsychotics 60 triacylglycerol 60 5-FU/LV 60 elevated hsCRP 60 DAS# remission 60 IRLS score 60 lipid lowering therapy 60 mIU ml 60 HGPIN 60 ULORIC 60 baseline FEV1 60 Calcium intake 60 metformin sulphonylurea 60 lymphocytosis 60 haemorrhagic stroke 60 idraparinux 60 UPDRS scores 60 acarbose 60 postprandial blood glucose 60 nocturnal hypoglycaemia 60 Secondary efficacy endpoints 60 log# reduction 60 HBV DNA levels 60 perioperative complications 60 creatine kinase 60 hematological parameters 60 CsA 60 severe periodontitis 60 sulphonylureas 60 urate lowering therapy 60 subcutaneous insulin 60 atherogenic 60 adjunctive placebo 60 pulmonary exacerbations 60 undetectable HCV RNA 60 AUC0 60 serum potassium levels 60 oral antidiabetic medications 60 placebo fluoxetine 60 unfractionated heparin 60 undetectable HBV DNA 60 nondepressed 60 hydroxyvitamin D concentrations 60 serum clusterin levels 60 HCTZ 60 thyroid stimulating hormone 60 XIENCE V PROMUS Stent 60 VLDL cholesterol 60 ALT elevation 60 blood glucose concentrations 60 POAG 60 annualized relapse 60 abnormal lipid 60 ApoB 60 hypogonadal 60 DAS# CRP 60 airway responsiveness 60 placebo p = 60 Visual Analogue Scale VAS 60 neurodevelopmental impairment 60 prehypertension 60 dose atorvastatin 60 biopsy Gleason 60 posttransplant 60 + PH# 60 carotid plaque 60 QIDS SR 60 Logistic regression analysis 60 Severity Index PASI 60 D dimer 60 maximal treadmill 60 APOC3 60 eNO 60 uric acid levels 60 dose colchicine 60 intraobserver 60 mRS 60 pretreatment baseline 60 serum phosphorus levels 60 Diastolic pressure 60 Cystatin C 60 sweat chloride 60 symptom exacerbation 60 fasting plasma 60 insulin degludec 60 CDAI 60 Brief Psychiatric 60 efficacy endpoint 60 carotid artery intima media 60 myocardial infarctions 60 ramipril 60 ETDRS 60 abciximab 60 mRNA expression 60 alkaline phosphatase 60 mg kg dose 60 adalimumab 60 cardiometabolic risk 60 p = NS 60 inotropic 60 hyperhomocysteinemia 60 μmol l 60 aminotransferase ALT 60 multivariate adjustment 60 Montgomery Asberg Depression 59 lymphocyte counts 59 Visual acuity 59 visceral adiposity 59 left ventricular hypertrophy 59 WOMAC pain 59 depressive symptom 59 trans fat intake 59 carotid artery thickness 59 severe renal impairment 59 -#.# log# 59 cTnI 59 flow mediated dilation 59 angiotensin receptor blockers ARBs 59 subscale scores 59 myocardial infarction MI 59 metabolite concentrations 59 hypophosphatemia 59 urinary calcium excretion 59 postprocedure 59 dietary intakes 59 lumbar spine bone 59 statistically nonsignificant 59 transaminase elevations 59 mcg dL 59 systolic pressure 59 lipid concentrations 59 diastolic function 59 mean baseline A1C 59 QRS duration 59 tPSA 59 QTc intervals 59 CC genotype 59 IU mL 59 HBeAg negative patients 59 % CI #.#-#.# [007] 59 covariates 59 antidiabetic therapy 59 Intraocular pressure 59 plasma homocysteine levels 59 ACR# ACR# 59 elevated LDL 59 esomeprazole 59 prednisone prednisolone 59 FOLPI 59 reach statistical significance 59 logistic regression model 59 Plasma concentrations 59 -#.# mmol L 59 nanograms milliliter 59 paraprotein 59 echocardiographic parameters 59 oral diclofenac 59 DLQI 59 daunorubicin 59 left ventricular diastolic 59 #-# mg dL 59 Hemoglobin A1c HbA1c 59 symptom severity 59 contrast induced nephropathy 59 UPDRS motor 59 glycemic control 59 inflammatory markers 59 salivary flow 59 alteplase 59 CPAP adherence 59 MMSE 59 rs# [002] 59 HDL LDL 59 coronary artery calcification 59 pyridostigmine 59 coronary calcification 59 nonobstructive CAD 59 Lantus ® 59 Univariate analysis 59 vertebral fracture 59 F FDG PET 59 NSTE ACS 59 intima media thickness IMT 59 DLTs 59 benazepril 59 NT proBNP 59 hydroxyvitamin D 59 VADT 59 albumin creatinine ratio 59 folate concentrations 59 ipsilateral stroke 59 CD4 + cell 59 lipoprotein levels 59 COHb 59 Diastolic 59 impaired glucose metabolism 59 Pharmacokinetic parameters 59 chlorambucil 59 nanomoles per 59 perioperative mortality 59 hepatic insulin sensitivity 59 BMI waist circumference 59 PON1 enzyme 59 Endothelial function 59 Flu Cy 59 pressor response 59 UKPDS 59 DASH diet 59 splenectomized patients 59 NovoLog ® Mix 59 thickness CIMT 59 baseline Hb 59 mg TID 59 mesalamine granules 59 MDRD 59 IOP lowering 59 olmesartan 59 radiographic progression 59 SGOT 59 depressive symptomatology 59 fibrinolysis 59 preintervention 59 Pred Forte 59 multivariate Cox 59 dosing cohort 59 serum insulin 59 racemic albuterol 59 posaconazole 59 left ventricular dysfunction 59 Stent thrombosis 59 adenotonsillectomy 59 montelukast 59 nonsignificant trend 59 XEPLION R 59 prostate cancer CaP 59 ug kg 59 sd = 59 Ramipril 59 neurocognitive function 59 hemodilution 59 HRQoL 59 sensory neuropathy 59 octreotide LAR 59 coadministration 59 interobserver reliability 59 MDRD equation 59 Operative mortality 59 detectable HCV RNA 59 LANTUS R 59 QTc prolongation 59 AZOR 59 #mg doses [002] 59 ventricular mass 59 hydroxy vitamin D 59 thiazide 59 test OGTT 59 interrater reliability 59 cerebral infarction 59 vasopressor 59 permanently discontinue Vectibix 59 rizatriptan 59 sodium nitroprusside 59 adrenal function 59 pioglitazone 59 covariate 59 hepatic enzymes 59 ß carotene 59 urine NGAL 59 antibody titers 59 white matter hyperintensities 59 flutamide 59 desvenlafaxine succinate 59 reflux symptoms 59 Elitek 59 ezetimibe simvastatin 59 autoantibody levels 59 FDA defined valvulopathy 59 sub maximal 59 IFN α 59 dysglycemia 59 secondary efficacy endpoint 59 preserved ejection fraction 59 URTI 59 NATRECOR ® 58 tiotropium 58 REYATAZ r arm 58 ug ml 58 fasting hyperglycemia 58 nonfatal stroke 58 posttest 58 IV bisphosphonates 58 μg dose 58 salmeterol fluticasone 58 triglycerides HDL 58 rosuvastatin Crestor 58 non fasting triglycerides 58 serum GGT 58 sociodemographic factors 58 nmol 58 thromboembolic events 58 4mg/kg 58 bioavailable testosterone 58 % CI #.#-#.# [001] 58 LDL Cholesterol